HRP20020816A2 - Pyridazinyl phenyl hydrazones useful against congestive heart failure - Google Patents
Pyridazinyl phenyl hydrazones useful against congestive heart failure Download PDFInfo
- Publication number
- HRP20020816A2 HRP20020816A2 HRP20020816A HRP20020816A2 HR P20020816 A2 HRP20020816 A2 HR P20020816A2 HR P20020816 A HRP20020816 A HR P20020816A HR P20020816 A2 HRP20020816 A2 HR P20020816A2
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- phenyl
- hydrogen
- pyridazin
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20000577A FI20000577A0 (fi) | 2000-03-13 | 2000-03-13 | Pyridatsinyylifenyylihydratsoneja |
| PCT/FI2001/000241 WO2001068611A1 (en) | 2000-03-13 | 2001-03-12 | Pyridazinyl phenyl hydrazones useful against congestive heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20020816A2 true HRP20020816A2 (en) | 2004-12-31 |
Family
ID=8557913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20020816 HRP20020816A2 (en) | 2000-03-13 | 2001-03-12 | Pyridazinyl phenyl hydrazones useful against congestive heart failure |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6699868B2 (et) |
| EP (1) | EP1265871B1 (et) |
| JP (1) | JP2003527375A (et) |
| KR (1) | KR20030001379A (et) |
| CN (1) | CN1191241C (et) |
| AR (1) | AR027644A1 (et) |
| AT (1) | ATE317388T1 (et) |
| AU (2) | AU4657701A (et) |
| BG (1) | BG65859B1 (et) |
| BR (1) | BR0109136A (et) |
| CA (1) | CA2403188A1 (et) |
| CZ (1) | CZ20022997A3 (et) |
| DE (1) | DE60117131T2 (et) |
| DK (1) | DK1265871T3 (et) |
| EA (1) | EA005574B1 (et) |
| EE (1) | EE200200520A (et) |
| ES (1) | ES2256222T3 (et) |
| FI (1) | FI20000577A0 (et) |
| HR (1) | HRP20020816A2 (et) |
| HU (1) | HUP0300177A3 (et) |
| IL (2) | IL151492A0 (et) |
| MX (1) | MXPA02008997A (et) |
| NO (1) | NO324172B1 (et) |
| NZ (1) | NZ521162A (et) |
| PL (1) | PL357107A1 (et) |
| RS (1) | RS50439B (et) |
| SI (1) | SI1265871T1 (et) |
| SK (1) | SK287163B6 (et) |
| UA (1) | UA74571C2 (et) |
| WO (1) | WO2001068611A1 (et) |
| ZA (1) | ZA200206917B (et) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0015228D0 (en) * | 2000-06-21 | 2000-08-16 | Portela & Ca Sa | Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders |
| JP4561698B2 (ja) * | 2002-02-19 | 2010-10-13 | 小野薬品工業株式会社 | 縮合ピリダジン誘導体化合物およびその化合物を有効成分として含有する薬剤 |
| WO2004087641A1 (ja) * | 2003-03-31 | 2004-10-14 | Daiichi Pharmaceutical Co., Ltd. | ヒドラゾン誘導体 |
| GB0503962D0 (en) | 2005-02-25 | 2005-04-06 | Kudos Pharm Ltd | Compounds |
| MX2009000884A (es) | 2006-07-25 | 2009-06-05 | Cephalon Inc | Derivados de piridizinona. |
| EP2117551A1 (en) * | 2007-01-17 | 2009-11-18 | Orion Corporation | Levosimendan for use in treating chronic valvular disease |
| US9447059B2 (en) | 2011-09-27 | 2016-09-20 | Zeon Corporation | Intermediate for manufacture of polymerizable compound and process for manufacture thereof |
| US9926282B2 (en) * | 2013-01-18 | 2018-03-27 | Bristol-Myers Squibb Company | Phthalazinones and isoquinolinones as rock inhibitors |
| EP3804707A4 (en) * | 2018-06-08 | 2022-03-16 | Nissan Chemical Corporation | KINASE INHIBITOR |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3531658A1 (de) | 1985-09-05 | 1987-03-12 | Boehringer Mannheim Gmbh | Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel |
| GB8903130D0 (en) | 1989-02-11 | 1989-03-30 | Orion Yhtymae Oy | Substituted pyridazinones |
| US5185332A (en) * | 1989-02-11 | 1993-02-09 | Orion-Yhtyma Oy | Thiadiazines and pharmaceutical compositions thereof as well as method of use |
| FI973804A7 (fi) * | 1997-09-26 | 1999-03-27 | Orion Yhtymae Oy | Levosimendaanin oraalisia koostumuksia |
-
2000
- 2000-03-13 FI FI20000577A patent/FI20000577A0/fi unknown
-
2001
- 2001-03-12 PL PL01357107A patent/PL357107A1/xx not_active Application Discontinuation
- 2001-03-12 HU HU0300177A patent/HUP0300177A3/hu unknown
- 2001-03-12 CA CA002403188A patent/CA2403188A1/en not_active Abandoned
- 2001-03-12 ES ES01919489T patent/ES2256222T3/es not_active Expired - Lifetime
- 2001-03-12 IL IL15149201A patent/IL151492A0/xx active IP Right Grant
- 2001-03-12 DE DE60117131T patent/DE60117131T2/de not_active Expired - Fee Related
- 2001-03-12 MX MXPA02008997A patent/MXPA02008997A/es active IP Right Grant
- 2001-03-12 AU AU4657701A patent/AU4657701A/xx active Pending
- 2001-03-12 SK SK1288-2002A patent/SK287163B6/sk not_active IP Right Cessation
- 2001-03-12 KR KR1020027012066A patent/KR20030001379A/ko not_active Ceased
- 2001-03-12 EA EA200200973A patent/EA005574B1/ru not_active IP Right Cessation
- 2001-03-12 AT AT01919489T patent/ATE317388T1/de not_active IP Right Cessation
- 2001-03-12 CN CNB018065309A patent/CN1191241C/zh not_active Expired - Fee Related
- 2001-03-12 AR ARP010101149A patent/AR027644A1/es unknown
- 2001-03-12 DK DK01919489T patent/DK1265871T3/da active
- 2001-03-12 EE EEP200200520A patent/EE200200520A/et unknown
- 2001-03-12 AU AU2001246577A patent/AU2001246577B2/en not_active Ceased
- 2001-03-12 WO PCT/FI2001/000241 patent/WO2001068611A1/en not_active Ceased
- 2001-03-12 BR BR0109136-0A patent/BR0109136A/pt not_active IP Right Cessation
- 2001-03-12 CZ CZ20022997A patent/CZ20022997A3/cs unknown
- 2001-03-12 RS YUP-685/02A patent/RS50439B/sr unknown
- 2001-03-12 EP EP01919489A patent/EP1265871B1/en not_active Expired - Lifetime
- 2001-03-12 US US10/221,348 patent/US6699868B2/en not_active Expired - Fee Related
- 2001-03-12 HR HRP20020816 patent/HRP20020816A2/hr not_active Application Discontinuation
- 2001-03-12 NZ NZ521162A patent/NZ521162A/en unknown
- 2001-03-12 SI SI200130518T patent/SI1265871T1/sl unknown
- 2001-03-12 JP JP2001567705A patent/JP2003527375A/ja not_active Withdrawn
- 2001-12-03 UA UA2002108100A patent/UA74571C2/uk unknown
-
2002
- 2002-08-26 IL IL151492A patent/IL151492A/en not_active IP Right Cessation
- 2002-08-28 ZA ZA200206917A patent/ZA200206917B/en unknown
- 2002-09-05 NO NO20024247A patent/NO324172B1/no not_active IP Right Cessation
- 2002-10-08 BG BG107175A patent/BG65859B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI105183B (fi) | Menetelmä sydämen vajaatoiminnan hoidossa käyttökelpoisen (-)-[[4-(1,4,5,6-tetrahydro-4-metyyli-6-okso-3-pyridatsinyyli)-fenyyli]hydratsono]propaanidinitriilin valmistamiseksi | |
| US6121266A (en) | Pyridazines as interleukin-1β converting enzyme inhibitors | |
| US20090306078A1 (en) | Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component | |
| JP7469522B2 (ja) | ベンゾチアゾール類誘導体及びその使用 | |
| HRP20020816A2 (en) | Pyridazinyl phenyl hydrazones useful against congestive heart failure | |
| JPH0570347A (ja) | 臓器用保護剤 | |
| JPH06508375A (ja) | インダン−1,3−ジオンおよびインダン−1,2,3−トリオンの誘導体、それらの調製方法およびそれらの治療上の使用 | |
| RU2156252C2 (ru) | Триазолопиридазины, способ их получения, фармацевтические композиции на их основе и способ лечения | |
| CN117903126B (zh) | 含炔基噻唑甲酰基的甘氨酰胺类化合物及其制备方法和应用 | |
| CN115724857B (zh) | 一种芳杂环类化合物、含其的药物组合物及其应用 | |
| Sircar et al. | Cardiotonic agents. 6. Synthesis and inotropic activity of 2, 4-dihydro-5-[4-(1H-imidazol-1-yl) phenyl]-3H-pyrazol-3-ones: ring-contracted analogs of imazodan (CI-914) | |
| US6323238B1 (en) | Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them | |
| CN113831323A (zh) | 芳杂环酰胺类化合物及其用途 | |
| CN112876419A (zh) | 烯丙胺衍生物及其制备方法和用途 | |
| HUP0201738A2 (hu) | Piridazinszármazékok alkalmazása ischémiás szövetkárosodás kezelésére alkalmas gyógyászati készítmények előállítására | |
| JP3159995B2 (ja) | トルイジン誘導体及びその製造方法 | |
| JP3553158B2 (ja) | ピリダジノインドール誘導体 | |
| EP3115359B1 (en) | Pyridazin-3(2h)-one derivatives which are selective inhibitors of the isoform b of monoamine oxidase | |
| HK40107460A (en) | Aromatic heterocyclic compound, pharmaceutical composition containing same, and use thereof | |
| CN104003983B (zh) | 含苯硒基取代的双杂环化合物及其制备与应用 | |
| WO2003067979A1 (fr) | Medicaments destines a etre utilises dans la transplantation d'organes | |
| JPS60197660A (ja) | ピリダジノン誘導体またはその塩類 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODBC | Application rejected |